The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions

The World Health Organization (WHO) living guideline on drugs to prevent COVID-19 has recently advised that ongoing trials evaluating hydroxychloroquine in chemoprophylaxis should stop. The WHO guideline cites “high certainty” evidence from randomised controlled trials (RCTs) that hydroxychloroquine...

Descripción completa

Detalles Bibliográficos
Autores principales: Schilling, William HK, Callery, James J., Chandna, Arjun, Hamers, Raph L, Watson, James A, White, Nicholas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Open Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356259/
https://www.ncbi.nlm.nih.gov/pubmed/34395925
http://dx.doi.org/10.12688/wellcomeopenres.16741.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356259/
https://www.ncbi.nlm.nih.gov/pubmed/34395925
http://dx.doi.org/10.12688/wellcomeopenres.16741.2

Ejemplares similares